Keppen Lubinsky Syndrome C3279800
A rare genetic disorder causing developmental delays, distinctive facial features, and skin abnormalities. It primarily affects children and requires lifelong supportive management of symptoms.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Severe developmental delay
(neurologic)Microcephaly
(neurologic)Generalized hypotonia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Metabolic complication surveillance
Regular monitoring of metabolic parameters including lipid panels, glucose levels, and liver function is essential given the hypertriglyceridemia and metabolic abnormalities characteristic of this syndrome. Imaging studies track organ involvement.
Specialized nutritional management
Dietary modification with restriction of simple carbohydrates and specific fat intake to manage hypertriglyceridemia. Consultation with a metabolic dietitian ensures adequate nutrition while controlling metabolic abnormalities.
Additional treatment options
Lipid-lowering therapy
Pharmacological management of severe hypertriglyceridemia using fibric acid derivatives or other lipid-lowering agents when dietary management alone is insufficient to prevent pancreatitis risk.
medicationDevelopmental and behavioral support
Psychological services addressing developmental delays and behavioral challenges associated with Keppen-Lubinsky Syndrome. Early intervention programs maximize developmental potential and address cognitive differences.
psychologicalMotor development intervention
Physical therapy targeting motor delays, hypotonia, and joint hypermobility to improve functional mobility and prevent secondary musculoskeletal complications. Developmental play activities incorporated into therapy.
physical_therapyWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Keppen Lubinsky Syndrome C3279800?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Keppen Lubinsky Syndrome C3279800. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy